← FDA Drug Approvals (Drugs@FDA)

KISQALI

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2017-03-13

Drug application

FDA Application #

NDA209092

Application type

New Drug Application

Brand name

KISQALI

Generic name

RIBOCICLIB

Active ingredients

RIBOCICLIB SUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2017-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown